371 related articles for article (PubMed ID: 23295955)
1. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
Lehtinen L; Ketola K; Mäkelä R; Mpindi JP; Viitala M; Kallioniemi O; Iljin K
Oncotarget; 2013 Jan; 4(1):48-63. PubMed ID: 23295955
[TBL] [Abstract][Full Text] [Related]
2. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma.
Liu X; Huang Y; Jiang C; Ou H; Guo B; Liao H; Li X; Yang D
Dig Liver Dis; 2016 Aug; 48(8):953-60. PubMed ID: 27257051
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
[TBL] [Abstract][Full Text] [Related]
5. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
[TBL] [Abstract][Full Text] [Related]
6. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.
Nilsson R; Jain M; Madhusudhan N; Sheppard NG; Strittmatter L; Kampf C; Huang J; Asplund A; Mootha VK
Nat Commun; 2014; 5():3128. PubMed ID: 24451681
[TBL] [Abstract][Full Text] [Related]
7. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
Li Q; Yang F; Shi X; Bian S; Shen F; Wu Y; Zhu C; Fu F; Wang J; Zhou J; Chen Y
FEBS Open Bio; 2021 Oct; 11(10):2845-2857. PubMed ID: 34231329
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
Yu C; Yang L; Cai M; Zhou F; Xiao S; Li Y; Wan T; Cheng D; Wang L; Zhao C; Huang X
J Cell Mol Med; 2020 Jan; 24(2):1568-1577. PubMed ID: 31778025
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
[TBL] [Abstract][Full Text] [Related]
10. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
[TBL] [Abstract][Full Text] [Related]
11. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
13. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
[TBL] [Abstract][Full Text] [Related]
14. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
16. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
Mo X; Liu Q; Liang K; Song Y
J Bioenerg Biomembr; 2024 Jun; 56(3):333-345. PubMed ID: 38488992
[TBL] [Abstract][Full Text] [Related]
17. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
Deng X; Wu X; Weng H; Song F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.
Wang SH; Zhang MD; Wu XC; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Sep; 37(9):12867-12875. PubMed ID: 27449039
[TBL] [Abstract][Full Text] [Related]
19. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells.
Wang PC; Weng CC; Hou YS; Jian SF; Fang KT; Hou MF; Cheng KH
Int J Mol Sci; 2014 Feb; 15(3):3560-79. PubMed ID: 24583847
[TBL] [Abstract][Full Text] [Related]
20. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
